The Management of Diabetes with Hyperuricemia: Can We Hit Two Birds with One Stone?

References

• Fatima T, Iftikhar S, Qureshi IH. Association between hyperuricemia and ischemic stroke: a case-control study. J Coll Physicians Surg Pak. 2020;30(8):853–856. doi:10.29271/jcpsp.2020.08.853
   PubMed Web of Science ®Google Scholar
• Chien KL, Chen MF, Hsu HC, et al. Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin Chem. 2008;54(2):310–316. doi:10.1373/clinchem.2007.095190
   PubMed Web of Science ®Google Scholar
• Stack AG, Dronamraju N, Parkinson J, et al. Effect of intensive urate lowering with combined verinurad and febuxostat on albuminuria in patients with type 2 diabetes: a randomized trial. Am J Kidney Dis. 2021;77(4):481–489. doi:10.1053/j.ajkd.2020.09.009
   PubMed Web of Science ®Google Scholar
• Tanaka A, Taguchi I, Teragawa H, et al. Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: a randomized, controlled trial. PLoS Med. 2020;17(4):e1003095. doi:10.1371/journal.pmed.1003095
   PubMed Web of Science ®Google Scholar
• Hu F, Zhang T. Study on risk factors of diabetic nephropathy in obese patients with type 2 diabetes mellitus. Int J Gen Med. 2020;13:351–360. doi:10.2147/ijgm.S255858
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Duman TT, Atak BM, Savli H. Is Uric Acid elevation a random finding or a causative agent of diabetic nephropathy? Rev Assoc Med Bras. 2019;65(9):1155–1160. doi:10.1590/1806-9282.65.9.1156
   PubMed Web of Science ®Google Scholar
• Aktas G, Kocak MZ, Bilgin S, Atak BM, Duman TT, Kurtkulagi O. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male. 2020;23(5):1098–1102. doi:10.1080/13685538.2019.1678126
   PubMed Web of Science ®Google Scholar
• Aktas G, Yilmaz S, Kantarci DB, et al. Is serum uric acid-to-HDL cholesterol ratio elevation associated with diabetic kidney injury? Postgrad Med. 2023;135(5):519–523. doi:10.1080/00325481.2023.2214058
   PubMed Web of Science ®Google Scholar
• Aktas G, Khalid A, Kurtkulagi O, et al. Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: a cross-sectional cohort study. Postgrad Med. 2022;134(3):297–302. doi:10.1080/00325481.2022.2039007
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Erkus E, Sincer I, Atak B, Duman T. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras. 2019;65(1):9–15. doi:10.1590/1806-9282.65.1.9
   PubMed Web of Science ®Google Scholar
• Kosekli MA, Kurtkulagii O, Kahveci G, et al. The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. Rev Assoc Med Bras. 2021;67(4):549–554. doi:10.1590/1806-9282.20201005
   PubMed Web of Science ®Google Scholar
• Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American diabetes association: national cross sectional study. BMJ. 2020;369:m997. doi:10.1136/bmj.m997
   PubMed Web of Science ®Google Scholar
• Dong X, Zhang H, Wang F, et al. Epidemiology and prevalence of hyperuricemia among men and women in Chinese rural population: the Henan rural cohort study. Mod Rheumatol. 2020;30(5):910–920. doi:10.1080/14397595.2019.1660048
   PubMed Web of Science ®Google Scholar
• Lu J, Sun W, Cui L, et al. A cross-sectional study on uric acid levels among Chinese adolescents. Pediatr Nephrol. 2020;35(3):441–446. doi:10.1007/s00467-019-04357-w
   PubMed Web of Science ®Google Scholar
• Lv Q, Meng X, He F, et al. High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PLoS One. 2013;8(2):e56864. doi:10.1371/journal.pone.0056864
   PubMed Web of Science ®Google Scholar
• Bhole V, Choi JW, Kim SW, de Vera M, Choi H. Serum uric acid levels and the risk of type 2 diabetes: a prospective study. Am J Med. 2010;123(10):957–961. doi:10.1016/j.amjmed.2010.03.027
   PubMed Web of Science ®Google Scholar
• Wang T, Bi Y, Xu M, et al. Serum uric acid associates with the incidence of type 2 diabetes in a prospective cohort of middle-aged and elderly Chinese. Endocrine. 2011;40(1):109–116. doi:10.1007/s12020-011-9449-2
   PubMed Web of Science ®Google Scholar
• Kodama S, Saito K, Yachi Y, et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009;32(9):1737–1742. doi:10.2337/dc09-0288
   PubMed Web of Science ®Google Scholar
• Cicerchi C, Li N, Kratzer J, et al. Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids. FASEB J. 2014;28(8):3339–3350. doi:10.1096/fj.13-243634
   PubMed Web of Science ®Google Scholar
• Neel JV. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”. Am J Hum Genet. 1962;14(4):353–362.
   PubMed Web of Science ®Google Scholar
• Wan X, Xu C, Lin Y, et al. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol. 2016;64(4):925–932. doi:10.1016/j.jhep.2015.11.022
   PubMed Web of Science ®Google Scholar
• Lu J, He Y, Cui L, et al. Hyperuricemia predisposes to the onset of diabetes via promoting pancreatic β-cell death in uricase-deficient male mice. Diabetes. 2020;69(6):1149–1163. doi:10.2337/db19-0704
   PubMed Web of Science ®Google Scholar
• Xu C, Wan X, Xu L, et al. Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: one stone hits two birds. J Hepatol. 2015;62(6):1412–1419. doi:10.1016/j.jhep.2015.01.019
   PubMed Web of Science ®Google Scholar
• Meng J, Li Y, Yuan X, Lu Y. Effects of febuxostat on insulin resistance and expression of high-sensitivity C-reactive protein in patients with primary gout. Rheumatol Int. 2017;37(2):299–303. doi:10.1007/s00296-016-3612-2
   PubMed Web of Science ®Google Scholar
• Takagi M, Babazono T, Uchigata Y. Differences in risk factors for the onset of albuminuria and decrease in glomerular filtration rate in people with Type 2 diabetes mellitus: implications for the pathogenesis of diabetic kidney disease. Diabet Med. 2015;32(10):1354–1360. doi:10.1111/dme.12793
   PubMed Web of Science ®Google Scholar
• Han T, Lan L, Qu R, et al. Temporal relationship between hyperuricemia and insulin resistance and its impact on future risk of hypertension. Hypertension. 2017;70(4):703–711. doi:10.1161/hypertensionaha.117.09508
   PubMed Web of Science ®Google Scholar
• Pfister R, Barnes D, Luben R, et al. No evidence for a causal link between uric acid and type 2 diabetes: a Mendelian randomisation approach. Diabetologia. 2011;54(10):2561–2569. doi:10.1007/s00125-011-2235-0
   PubMed Web of Science ®Google Scholar
• Keenan T, Zhao W, Rasheed A, et al. Causal assessment of serum urate levels in cardiometabolic diseases through a Mendelian randomization study. J Am Coll Cardiol. 2016;67(4):407–416. doi:10.1016/j.jacc.2015.10.086
   PubMed Web of Science ®Google Scholar
• Sluijs I, Holmes MV, van der Schouw YT, et al. A Mendelian randomization study of circulating uric acid and type 2 diabetes. Diabetes. 2015;64(8):3028–3036. doi:10.2337/db14-0742
   PubMed Web of Science ®Google Scholar
• Volpe A, Ye C, Hanley AJ, Connelly PW, Zinman B, Retnakaran R. Changes over time in uric acid in relation to changes in insulin sensitivity, beta-cell function, and glycemia. J Clin Endocrinol Metab. 2020;105(3):e651–9. doi:10.1210/clinem/dgz199
   PubMed Web of Science ®Google Scholar
• Jia L, Xing J, Ding Y, et al. Hyperuricemia causes pancreatic β-cell death and dysfunction through NF-κB signaling pathway. PLoS One. 2013;8(10):e78284. doi:10.1371/journal.pone.0078284
   PubMed Web of Science ®Google Scholar
• Tang W, Fu Q, Zhang Q, et al. The association between serum uric acid and residual β -cell function in type 2 diabetes. J Diabetes Res. 2014;2014:709691. doi:10.1155/2014/709691
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yamamoto T, Hisatome I, et al. Uric acid induces oxidative stress and growth inhibition by activating adenosine monophosphate-activated protein kinase and extracellular signal-regulated kinase signal pathways in pancreatic β cells. Mol Cell Endocrinol. 2013;375(1–2):89–96. doi:10.1016/j.mce.2013.04.027
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhao H, Lu J, et al. High uric acid promotes dysfunction in pancreatic β cells by blocking IRS2/AKT signalling. Mol Cell Endocrinol. 2021;520:111070. doi:10.1016/j.mce.2020.111070
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Erkus E, et al. Neuregulin-4 is associated with plasma glucose and increased risk of type 2 diabetes mellitus. Swiss Med Wkly. 2019;149:w20139. doi:10.4414/smw.2019.20139
   PubMed Web of Science ®Google Scholar
• Braga TT, Forni MF, Correa-Costa M, et al. Soluble Uric Acid Activates the NLRP3 Inflammasome. Sci Rep. 2017;7:39884. doi:10.1038/srep39884
   PubMed Web of Science ®Google Scholar
• Rheinheimer J, de Souza BM, Cardoso NS, Bauer AC, Crispim D. Current role of the NLRP3 inflammasome on obesity and insulin resistance: a systematic review. Metabolism. 2017;74:1–9. doi:10.1016/j.metabol.2017.06.002
   PubMed Web of Science ®Google Scholar
• Resl M, Clodi M, Neuhold S, et al. Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus. Diabet Med. 2012;29(6):721–725. doi:10.1111/j.1464-5491.2011.03515.x
   PubMed Web of Science ®Google Scholar
• Bjornstad P, Paul Wadwa R, Sirota J, et al. Serum uric acid and hypertension in adults: a paradoxical relationship in type 1 diabetes. J Clin Hypertens. 2014;16(4):283–288. doi:10.1111/jch.12305
   Web of Science ®Google Scholar
• Bjornstad P, Laffel L, Lynch J, et al. Elevated serum uric acid is associated with greater risk for hypertension and diabetic kidney diseases in obese adolescents with type 2 diabetes: an observational analysis from the treatment options for type 2 diabetes in adolescents and youth (TODAY) study. Diabetes Care. 2019;42(6):1120–1128. doi:10.2337/dc18-2147
   PubMed Web of Science ®Google Scholar
• Yan D, Wang J, Jiang F, et al. A causal relationship between uric acid and diabetic macrovascular disease in Chinese type 2 diabetes patients: a Mendelian randomization analysis. Int J Cardiol. 2016;214:194–199. doi:10.1016/j.ijcard.2016.03.206
   PubMed Web of Science ®Google Scholar
• Lytvyn Y, Perkins B, Cherney D. Uric acid as a biomarker and a therapeutic target in diabetes. Can J Diabetes. 2015;39(3):239–246. doi:10.1016/j.jcjd.2014.10.013
   PubMed Web of Science ®Google Scholar
• Bartáková V, Kuricová K, Pácal L, et al. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus. J Diabetes Complications. 2016;30(7):1300–1307. doi:10.1016/j.jdiacomp.2016.06.002
   PubMed Web of Science ®Google Scholar
• Chen Z, Ding Z, Fu C, Yu C, Ma G. Correlation between serum uric Acid and renal function in patients with stable coronary artery disease and type 2 diabetes. J Clin Med Res. 2014;6(6):443–450. doi:10.14740/jocmr1909w
   PubMedGoogle Scholar
• Pilemann-Lyberg S, Hansen T, Persson F, et al. Uric acid is not associated with diabetic nephropathy and other complications in type 1 diabetes. Nephrol Dial Transplant. 2019;34(4):659–666. doi:10.1093/ndt/gfy076
   PubMed Web of Science ®Google Scholar
• Pilemann-Lyberg S, Hansen T, Tofte N, et al. Uric acid is an independent risk factor for decline in kidney function, cardiovascular events, and mortality in patients with type 1 diabetes. Diabetes Care. 2019;42(6):1088–1094. doi:10.2337/dc18-2173
   PubMed Web of Science ®Google Scholar
• Ahola A, Sandholm N, Forsblom C, Harjutsalo V, Dahlström E, Groop P. The serum uric acid concentration is not causally linked to diabetic nephropathy in type 1 diabetes. Kidney Int. 2017;91(5):1178–1185. doi:10.1016/j.kint.2016.11.025
   PubMed Web of Science ®Google Scholar
• Mizuno Y, Yamamotoya T, Nakatsu Y, et al. Xanthine oxidase inhibitor febuxostat exerts an anti-inflammatory action and protects against diabetic nephropathy development in KK-ay obese diabetic mice. Int J Mol Sci. 2019;20(19):4680. doi:10.3390/ijms20194680
   PubMed Web of Science ®Google Scholar
• Sangüesa G, Roglans N, Montañés J, et al. Chronic liquid fructose, but not glucose, supplementation selectively induces visceral adipose tissue leptin resistance and hypertrophy in female Sprague-Dawley rats. Mol Nutr Food Res. 2018;62(22):e1800777. doi:10.1002/mnfr.201800777
   PubMed Web of Science ®Google Scholar
• Murphy R, Thornley S, de Zoysa J, Stamp L, Dalbeth N, Merriman T. Sugar sweetened beverage consumption among adults with gout or type 2 diabetes. PLoS One. 2015;10(5):e0125543. doi:10.1371/journal.pone.0125543
   PubMed Web of Science ®Google Scholar
• Sun Y, Sun J, Zhang P, Zhong F, Cai J, Ma A. Association of dietary fiber intake with hyperuricemia in U.S. adults. Food Funct. 2019;10(8):4932–4940. doi:10.1039/c8fo01917g
   PubMed Web of Science ®Google Scholar
• Žuvela P, David J, Yang X, Huang D, Wong MW. Non-linear quantitative structure⁻activity relationships modelling, mechanistic study and in-silico design of flavonoids as potent antioxidants. Int J Mol Sci. 2019;20(9):2328. doi:10.3390/ijms20092328
   PubMed Web of Science ®Google Scholar
• Choi HK, Gao X, Curhan G. Vitamin C intake and the risk of gout in men: a prospective study. Arch Intern Med. 2009;169(5):502–507. doi:10.1001/archinternmed.2008.606
   PubMedGoogle Scholar
• Teng G, Pan A, Yuan J, Koh W. Food sources of protein and risk of incident gout in the Singapore Chinese health study. Arthritis Rheumatol. 2015;67(7):1933–1942. doi:10.1002/art.39115
   PubMed Web of Science ®Google Scholar
• Liu X, Wu Q, Chen Z, et al. Elevated triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio increased risk of hyperuricemia: a 4-year cohort study in China. Endocrine. 2020;68(1):71–80. doi:10.1007/s12020-019-02176-5
   PubMed Web of Science ®Google Scholar
• Yokose C, McCormick N, Rai SK, et al. Effects of low-fat, Mediterranean, or low-carbohydrate weight loss diets on serum urate and cardiometabolic risk factors: a secondary analysis of the dietary intervention randomized controlled trial (DIRECT). Diabetes Care. 2020;43(11):2812–2820. doi:10.2337/dc20-1002
   PubMed Web of Science ®Google Scholar
• Bergia RE, Giacco R, Hjorth T, et al. Differential glycemic effects of low- versus high-glycemic index Mediterranean-style eating patterns in adults at risk for type 2 diabetes: the medgi-carb randomized controlled trial. Nutrients. 2022;14(3):706. doi:10.3390/nu14030706
   PubMed Web of Science ®Google Scholar
• Kontogianni M, Chrysohoou C, Panagiotakos D, et al. Adherence to the Mediterranean diet and serum uric acid: the ATTICA study. Scand J Rheumatol. 2012;41(6):442–449. doi:10.3109/03009742.2012.679964
   PubMed Web of Science ®Google Scholar
• Kobylecki C, Afzal S, Nordestgaard B. Genetically high plasma vitamin C and urate: a Mendelian randomization study in 106 147 individuals from the general population. Rheumatology. 2018;57(10):1769–1776. doi:10.1093/rheumatology/key171
   PubMed Web of Science ®Google Scholar
• Qin X, Li Y, He M, et al. Folic acid therapy reduces serum uric acid in hypertensive patients: a substudy of the China Stroke Primary Prevention Trial (CSPPT). Am J Clin Nutr. 2017;105(4):882–889. doi:10.3945/ajcn.116.143131
   PubMed Web of Science ®Google Scholar
• Oshima S, Shiiya S, Nakamura Y. Serum uric acid-lowering effects of combined glycine and tryptophan treatments in subjects with mild hyperuricemia: a randomized, double-blind, placebo-controlled, crossover study. Nutrients. 2019;11(3). doi:10.3390/nu11030564
   Web of Science ®Google Scholar
• Zhang Y, Qiu H. Dietary magnesium intake and hyperuricemia among US adults. Nutrients. 2018;10(3). doi:10.3390/nu10030296
   Web of Science ®Google Scholar
• Zhang Y, Liu Y, Qiu H. Association between dietary zinc intake and hyperuricemia among adults in the United States. Nutrients. 2018;10(5). doi:10.3390/nu10050568
   Web of Science ®Google Scholar
• American Diabetes A. 4. lifestyle management: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl1):S38–S50. doi:10.2337/dc18-S004
   PubMedGoogle Scholar
• Nieuwoudt S, Fealy C, Foucher J, et al. Functional high-intensity training improves pancreatic β-cell function in adults with type 2 diabetes. Am J Physiol Endocrinol Metab. 2017;313(3):E314–E320. doi:10.1152/ajpendo.00407.2016
   PubMed Web of Science ®Google Scholar
• Toyoki D, Shibata S, Kuribayashi-Okuma E, et al. Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and ATP-binding cassette subfamily G member 2. Am J Physiol Renal Physiol. 2017;313(3):F826–F834. doi:10.1152/ajprenal.00012.2017
   PubMed Web of Science ®Google Scholar
• Maalouf N, Poindexter J, Adams-Huet B, Moe O, Sakhaee K. Increased production and reduced urinary buffering of acid in uric acid stone formers is ameliorated by pioglitazone. Kidney Int. 2019;95(5):1262–1268. doi:10.1016/j.kint.2018.11.024
   PubMed Web of Science ®Google Scholar
• Niu S, Chang K, Lin H, et al. Decreased incidence of gout in diabetic patients using pioglitazone. Rheumatology. 2018;57(1):92–99. doi:10.1093/rheumatology/kex363
   PubMed Web of Science ®Google Scholar
• Zhao Y, Xu L, Tian D, et al. Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on serum uric acid level: a meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2018;20(2):458–462. doi:10.1111/dom.13101
   PubMed Web of Science ®Google Scholar
• Omolekulo T, Michael O, Olatunji L. Dipeptidyl peptidase-4 inhibition protects the liver of insulin-resistant female rats against triglyceride accumulation by suppressing uric acid. Biomed Pharmacother. 2019;110:869–877. doi:10.1016/j.biopha.2018.12.036
   PubMed Web of Science ®Google Scholar
• Tonneijck L, Muskiet M, Smits M, et al. Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: post-hoc analyses of four clinical trials. Diabetes Obes Metab. 2018;20(5):1235–1245. doi:10.1111/dom.13223
   PubMed Web of Science ®Google Scholar
• Vargas-Santos A, Peloquin C, Zhang Y, Neogi T. Association of chronic kidney disease with allopurinol use in gout treatment. JAMA Intern Med. 2018;178(11):1526–1533. doi:10.1001/jamainternmed.2018.4463
   PubMed Web of Science ®Google Scholar
• Singh J, Cleveland J. Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data. Ann Rheum Dis. 2020;79(4):529–535. doi:10.1136/annrheumdis-2019-216917
   PubMed Web of Science ®Google Scholar
• FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American college of rheumatology guideline for the management of gout. Arthritis Rheumatol. 2020;72(6):879–895. doi:10.1002/art.41247
   PubMed Web of Science ®Google Scholar
• Niu S, Chang K, Ta A, et al. Decreased incidence of diabetes in patients with gout using benzbromarone. Rheumatology. 2018;57(9):1574–1582. doi:10.1093/rheumatology/key138
   PubMed Web of Science ®Google Scholar
• Komers R, Xu B, Schneider J, Oyama T. Effects of xanthine oxidase inhibition with febuxostat on the development of nephropathy in experimental type 2 diabetes. Br J Pharmacol. 2016;173(17):2573–2588. doi:10.1111/bph.13527
   PubMed Web of Science ®Google Scholar
• Yisireyili M, Hayashi M, Wu H, et al. Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in mice. Sci Rep. 2017;7(1):1266. doi:10.1038/s41598-017-01366-3
   PubMedGoogle Scholar
• Pilemann-Lyberg S, Persson F, Frystyk J, Rossing P. The effect of uric acid lowering treatment on albuminuria and renal function in Type 1 diabetes: a randomized clinical trial. Diabet Med. 2018;35(3):392–393. doi:10.1111/dme.13577
   PubMed Web of Science ®Google Scholar
• Saag KG, Whelton A, Becker MA, MacDonald P, Hunt B, Gunawardhana L. Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal Impairment. Arthritis Rheumatol. 2016;68(8):2035–2043. doi:10.1002/art.39654
   PubMed Web of Science ®Google Scholar
• Beddhu S, Filipowicz R, Wang B, et al. A randomized controlled trial of the effects of febuxostat therapy on adipokines and markers of kidney fibrosis in asymptomatic hyperuricemic patients with diabetic nephropathy. Can J Kidney Health Dis. 2016;3:2054358116675343. doi:10.1177/2054358116675343
   Google Scholar
• Doria A, Galecki AT, Spino C, et al. Serum urate lowering with allopurinol and kidney function in type 1 diabetes. N Engl J Med. 2020;382(26):2493–2503. doi:10.1056/NEJMoa1916624
   PubMed Web of Science ®Google Scholar
• Tomiyama H, Shiina K, Vlachopoulos C, et al. Involvement of arterial stiffness and inflammation in hyperuricemia-related development of hypertension. Hypertension. 2018;72(3):739–745. doi:10.1161/hypertensionaha.118.11390
   PubMed Web of Science ®Google Scholar
• Choi H, Soriano L, Zhang Y, Rodríguez L. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ. 2012; 344:d8190. doi:10.1136/bmj.d8190
   PubMed Web of Science ®Google Scholar
• Lu J, Sun M, Wu X, et al. Urate-lowering therapy alleviates atherosclerosis inflammatory response factors and neointimal lesions in a mouse model of induced carotid atherosclerosis. FEBS J. 2019;286(7):1346–1359. doi:10.1111/febs.14768
   PubMed Web of Science ®Google Scholar
• Waldman B, Ansquer J, Sullivan D, et al. Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study. Lancet Diabetes Endocrinol. 2018;6(4):310–318. doi:10.1016/s2213-8587(18)30029-9
   PubMed Web of Science ®Google Scholar
• Derosa G, Maffioli P, Reiner Ž, Simental-Mendía L, Sahebkar A. Impact of statin therapy on plasma uric acid concentrations: a systematic review and meta-analysis. Drugs. 2016;76(9):947–956. doi:10.1007/s40265-016-0591-2
   PubMed Web of Science ®Google Scholar
• Zhang P, Wang H, Chen X, Liang W, Liu W, Liu M. Effect of low-dose aspirin on serum uric acid levels in Chinese individuals over 60: subanalysis of a multicentre randomized clinical trial. Eur Rev Med Pharmacol Sci. 2020;24(5):2719–2724. doi:10.26355/eurrev_202003_20544
   PubMed Web of Science ®Google Scholar
• Hargreaves S, Hawley M, Haywood A, Enderby P. Informing the design of “lifestyle monitoring” technology for the detection of health deterioration in long-term conditions: a qualitative study of people living with heart failure. J Med Internet Res. 2017;19(6):e231. doi:10.2196/jmir.6931
   PubMed Web of Science ®Google Scholar
• Dugstad J, Eide T, Nilsen E, Eide H. Towards successful digital transformation through co-creation: a longitudinal study of a four-year implementation of digital monitoring technology in residential care for persons with dementia. BMC Health Serv Res. 2019;19(1):366. doi:10.1186/s12913-019-4191-1
   PubMed Web of Science ®Google Scholar
• Su D, Michaud T, Estabrooks P, et al. Diabetes management through remote patient monitoring: the importance of patient activation and engagement with the technology. Telemed J E Health. 2019;25(10):952–959. doi:10.1089/tmj.2018.0205
   PubMed Web of Science ®Google Scholar
• Gao W, Emaminejad S, Nyein H, et al. Fully integrated wearable sensor arrays for multiplexed in situ perspiration analysis. Nature. 2016;529(7587):509–514. doi:10.1038/nature16521
   PubMed Web of Science ®Google Scholar
• Yang Y, Song Y, Bo X, et al. A laser-engraved wearable sensor for sensitive detection of uric acid and tyrosine in sweat. Nat Biotechnol. 2020;38(2):217–224. doi:10.1038/s41587-019-0321-x
   PubMed Web of Science ®Google Scholar